Understanding Thyroid Carcinoma: Clinical Manifestations, Diagnosis, and Management
DOI:
10.29303/jbt.v24i4.7664Published:
2024-10-28Downloads
Abstract
Thyroid carcinoma holds the 11th place in the incidence of new cancers, with a prevalence of 586,202 cases worldwide. The incidence of thyroid cancer in Indonesia reached 13,114 cases with 2,224 mortality in 2020. This literature review aims to provide information on thyroid cancer's clinical manifestations, diagnosis, and management. We conducted a literature searching from books, literature reviews, case studies, and guidelines from professional organizations such as the AJCC (American Joint Committee on Cancer) and European Society for Medical Oncology (ESMO) guideline. The initially noticed clinical manifestation of thyroid cancer is usually a painless lump or enlargement at the front-lower part of the neck. Diagnosis of thyroid cancer is done step-by-step from history taking, physical examination, laboratory testing of thyroid stimulating hormone and thyroglobulin, thyroid ultrasonography, and fine needle aspiration biopsy (FNAB). Management of thyroid cancer include pharmacological management, surgery, or/and radiotherapy according to the type and stage of the thyroid cancer. Early diagnosis and therapy of thyroid cancer are expected to improve the prognosis of thyroid cancer.
Keywords:
Cancer, carcinoma, fine needle aspiration, thyroid.References
Adham, M. and Aldino, N. (2019) ‘Diagnosis Dan Tatalaksana Karsinoma Tiroid Berdiferensiasi’, Oto Rhino Laryngologica Indonesiana, 48(2), p. 197. doi: 10.32637/orli.v48i2.270.
Albi, E., Cataldi, S., Lazzarini, A., Codini, M., Beccari, T., Saverio, F., & Curcio, F. (2017). Radiation and Thyroid Cancer. International Journal of Molecular Sciences, 18(5), 911. https://doi.org/10.3390/ijms18050911.
American Joint Committee on Cancer. (2018). AJCC Cancer Staging Manual. 8th Edition. Springer, Chicago. ISBN 978-0-9968262-9-7, DOI 10.1007/978-3-319-40618-3, pp: 881-910.
Amir, N. A. B., Kasprata, H. N., Priyahita, P. D., Syahla, T., and Triani, E. (2023). Clinical Diagnosis and Management of Thyroid Cancer. Jurnal Kedokteran Unram, DOI: 10.29303/jku.v12i3.96.
Baloch, Z. W., Asa, S. L., Barletta, J. A., Ghossein, R. A., Juhlin, C. C., Jung, C. K., LiVolsi, V. A., Papotti, M. G., Sobrinho-Simões, M., Tallini, G., & Mete, O. (2022). Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocrine pathology, 33(1), 27–63. https://doi.org/10.1007/s12022-022-09707-3.
Bickley, L.S. & Szilagyi, P.G. (2017). Bates’ Guide to Physical Examination and History Taking. 12th Ed. Wolters Kluwer, Philadelphia. ISBN 9781469893419.
Carling, T., & Udelsman, R. (2014). Thyroid cancer. Annual review of medicine, 65, 125–137. https://doi.org/10.1146/annurev-med-061512-105739.
Coca-Pelaz, A., Rodrigo, J. P., Shah, J. P., Sanabria, A., Al Ghuzlan, A., Silver, C. E., Shaha, A. R., Angelos, P., Hartl, D. M., Mäkitie, A. A., Olsen, K. D., Owen, R. P., Randolph, G. W., Simó, R., Tufano, R. P., Kowalski, L. P., Zafereo, M. E., Rinaldo, A., & Ferlito, A. (2021). Hürthle Cell Carcinoma of the Thyroid Gland: Systematic Review and Meta-analysis. Advances in therapy, 38(10), 5144–5164. https://doi.org/10.1007/s12325-021-01876-7.
Columbia Surgery (2024). Thyroid Cancer Diagnosis. Columbia University Irving Medical Center, Department of Surgery. https://columbiasurgery.org/thyroid/thyroid-cancer-diagnosis.
Denaro, N., Romanò, R., Alfieri, S., Dolci, A., Licitra, L., Nuzzolese, I., Ghidini, M., Bareggi, C., Bertaglia, V., Solinas, C., & Garrone, O. (2023). The Tumor Microenvironment and the Estrogen Loop in Thyroid Cancer. Cancers, 15(9). https://doi.org/10.3390/cancers15092458.
Dideban, S., Abdollahi, A., Meysamie, A., Sedghi, S., & Shahriari, M. (2015). Thyroid Papillary Microcarcinoma: Etiology, Clinical Manifestations,Diagnosis, Follow-up, Histopathology and Prognosis. Iranian Journal of Pathology, 11(1), 1-19. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749190/.
Fefar, A.D., Gohel, U., Mistry, S.N., Khavdu, P.J., Mehta, M.R. (2016). Papillary carcinoma of thyroid-an unusual lateral neck presentation. Indian Journal of Anatomy and Surgery of Head, Neck and Brain, 2(4), 114–115. https://doi.org/10.18231/2455-846X.2016.0008.
Filetti, S., Durante, C., Hartl, D., Leboulleux, S., Locati, L. D., Newbold, K., Papotti, M. G., Berruti, A., & ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org (2019). Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Annals of oncology : official journal of the European Society for Medical Oncology, 30(12), 1856–1883. https://doi.org/10.1093/annonc/mdz400.
Ganly, I., Makarov, V., Deraje, S., Dong, Y., Reznik, E., Seshan, V., Nanjangud, G., Eng, S., Bose, P., Kuo, F., Morris, L. G. T., Landa, I., Carrillo Albornoz, P. B., Riaz, N., Nikiforov, Y. E., Patel, K., Umbricht, C., Zeiger, M., Kebebew, E., Sherman, E., … Chan, T. A. (2018). Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes. Cancer cell, 34(2), 256–270.e5. https://doi.org/10.1016/j.ccell.2018.07.002.
Haddad, R. I., Bischoff, L., Ball, D., Bernet, V., Blomain, E., Busaidy, N. L., Campbell, M., Dickson, P., Duh, Q. Y., Ehya, H., Goldner, W. S., Guo, T., Haymart, M., Holt, S., Hunt, J. P., Iagaru, A., Kandeel, F., Lamonica, D. M., Mandel, S., Markovina, S., … Darlow, S. (2022). Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 20(8), 925–951. https://doi.org/10.6004/jnccn.2022.0040.
Hao, Z., Cui, H., Li, Y., Wu, W., Wang, Y., Dan, H., Lou, L., Wang, H., & Zhao, P. (2024). Simultaneous occurrence of papillary thyroid carcinoma, medullary thyroid carcinoma, and lymphoma: A case report. Medicine, 103(33), e39363. https://doi.org/10.1097/MD.0000000000039363.
Harari, A., & Singh, R. K. (2016). Increased rates of advanced thyroid cancer in California. Journal of Surgical Research, 201(1), 244-252. https://doi.org/10.1016/j.jss.2015.10.037
Ito, Y., Hirokawa, M., Fujishima, M., Masuoka, H., Higashiyama, T., Kihara, M., Onoda, N., Miya, A., & Miyauchi, A. (2021). Prognostic significance of vascular invasion and cell-proliferation activity in widely invasive follicular carcinoma of the thyroid. Endocrine journal, 68(8), 881–888. https://doi.org/10.1507/endocrj.EJ21-0064.
Jannin, A., Escande, A., Al Ghuzlan, A., Blanchard, P., Hartl, D., Chevalier, B., ... & Dupuy, C. (2022). Anaplastic thyroid carcinoma: an update. Cancers 2022 14 1061. Endocrine and Neuroendocrine Cancers, 103. https://doi.org/10.3390/ cancers14041061.
Jiang, L., Chu, H., & Zheng, H. (2016). B-Raf mutation and papillary thyroid carcinoma patients. Oncology letters, 11(4), 2699–2705. https://doi.org/10.3892/ol.2016.4298.
Khan, S. A., Aziz, A., Esbhani, U. A., & Masood, M. Q. (2022). Medullary Thyroid Cancer: An Experience from a Tertiary Care Hospital of a Developing Country. Indian journal of endocrinology and metabolism, 26(1), 68–72. https://doi.org/10.4103/ijem.ijem_474_21.
Kitahara, C. M., K Rmendiné Farkas, D., Jørgensen, J. O. L., Cronin-Fenton, D., & Sørensen, H. T. (2018). Benign Thyroid Diseases and Risk of Thyroid Cancer: A Nationwide Cohort Study. The Journal of clinical endocrinology and metabolism, 103(6), 2216–2224. https://doi.org/10.1210/jc.2017-02599.
Kure, S., & Ohashi, R. (2020). Thyroid Hürthle Cell Carcinoma: Clinical, Pathological, and Molecular Features. Cancers, 13(1), 26. https://doi.org/10.3390/cancers13010026.
Lam A. K. (2022). Papillary Thyroid Carcinoma: Current Position in Epidemiology, Genomics, and Classification. Methods in molecular biology (Clifton, N.J.), 2534, 1–15. https://doi.org/10.1007/978-1-0716-2505-7_1.
Marcello, M. A., Cunha, L. L., Batista, F. A., & Ward, L. S. (2014). Obesity and thyroid cancer. Endocrine-Related Cancer, 21(5), T255-T271. Retrieved Oct 14, 2024, https://doi.org/10.1530/ERC-14-0070.
National Cancer Institute. (2024). Thyroid Cancer Treatment (PDQ®)-Health Professional Version. US Department of Health and Human Services. https://www.cancer.gov/types/thyroid/hp/thyroid-treatment-pdq.
Nguyen, Q. T., Lee, E. J., Huang, M. G., Park, Y. I., Khullar, A., & Plodkowski, R. A. (2015). Diagnosis and Treatment of Patients with Thyroid Cancer. American Health & Drug Benefits, 8(1), 30-40. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415174/.
Park, S. Y., Kim, H. I., Kim, J. H., Kim, J. S., Oh, Y. L., Kim, S. W., Chung, J. H., Jang, H. W., & Kim, T. H. (2018). Prognostic significance of gross extrathyroidal extension invading only strap muscles in differentiated thyroid carcinoma. The British journal of surgery, 105(9), 1155–1162. https://doi.org/10.1002/bjs.10830.
Raman, P., & Koenig, R. J. (2014). PAX8-PPARγ fusion protein in thyroid carcinoma. Nature Reviews. Endocrinology, 10(10), 616. https://doi.org/10.1038/nrendo.2014.115
Shah, J. P. (2015). Thyroid Carcinoma: Epidemiology, Histology, and Diagnosis. Clinical Advances in Hematology & Oncology : H&O, 13(4 Suppl 4), 3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526593/.
Shen, J., Yan, M., Chen, L., Ou, D., Yao, J., Feng, N., Zhou, X., Lei, Z., & Xu, D. (2023). Prognosis and influencing factors of follicular thyroid cancer. Cancer Medicine, 13(1). https://doi.org/10.1002/cam4.6727.
Siregar, K. B. (2023) ‘Kanker Tiroid: Penjelasan Komprehensif Tentang Kanker Tiroid’, Perpustakaan Nasional : Katalog Dalam Terbitan (KDT), pp. 1–23.
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660.
License
Copyright (c) 2024 Rima Cahyati Kusumadewi, Rukmanggana Satya Pratiwi, Artiani Tresna Imut Exhasna, Gina Aulia Azizaturrahmah, I Gede Pande Devin Agastya Sastrawan, Rosita Wenilia, Syihabul Muttaqin, Dita Supriantarini, M. Arya Rifqi Ilham, Walid Rivaldi Fatahillah, Eva Triani
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
